Enterprise Solutions Webinars

  1. Enhanced Biotherapeutic Protein Expression Using Advanced Vector Systems 3/18/2026

    Learn how optimized expression vector design and data-driven strategies can significantly enhance product titre, quality, and long-term gene expression stability in GS-CHO cell-based manufacturing.

  2. Cytovance Biologics Capabilities Update March 2026: Large Molecule 3/17/2026

    How a seasoned development and manufacturing team blends technical depth, reliability, and flexible support to advance large‑molecule programs amid shifting timelines, costs, and regulatory demands.

  3. Trends In Mid-Size Scale Up Strategies 3/13/2026

    A development leader highlights supply‑chain resilience, cost‑efficient large‑scale manufacturing, proven tech‑transfer success, and long‑term commitment to supporting clients through reliable scale‑up and global production strategies.

  4. LNP And Liposomal Center Of Excellence 3/10/2026

    A connected development pathway supports smoother scale-up and greater consistency for LNP-based therapeutics. Explore how integrated expertise across key stages helps teams accelerate progress.

  5. The Tradeoffs Of Continuous Processing 3/9/2026

    Continuous bioprocessing has real benefits from a productivity standpoint, but it’s not inherently the best model for every process, especially in early stage development. In this segment from the Bioprocess Online Live event “Optimizing Process Development Through Upstream And Downstream Integration,” our panelists discuss how and when to approach continuous manufacturing, which can be great for commercial stage processes, but may not be worth the time or resources in Phase 1.

  6. Strategies For Robust Process Characterization And Validation To Accelerate Biologics Manufacturing 3/8/2026

    Uncover how data-driven process design, effective technology transfer, and robust process characterization can accelerate validation readiness and help move biologics from development to commercial success faster.

  7. Accelerator™ Drug Development 360° CDMO And CRO Solutions 3/4/2026

    Review this coordinated suite of integrated solutions that brings together CDMO and CRO capabilities across clinical research, manufacturing, and clinical supply.

  8. Facing Challenges In Gene Therapy Development 3/2/2026

    In this two-minute preview, we take a high-level look at the entire gene therapy development journey — from discovery and preclinical research to process development, manufacturing, regulatory engagement, and clinical trials.

  9. USP <665> Compliance Guidance 2/26/2026

    Experts address key USP <665> questions, including risk assessment, testing approaches, extractables and leachables, and practical challenges in implementing single‑use systems in manufacturing.

  10. Integrated Thinking for Complex FIH Programs 2/25/2026

    See how deep expertise, integrated thinking, and cross-functional collaboration turn complex molecule challenges into opportunities, strengthening early decisions and improving First‑in‑Human outcomes.